Skip to main content
. 2015 Jun 1;26(11):2054–2066. doi: 10.1091/mbc.E14-10-1473

FIGURE 6:

FIGURE 6:

Intracellular induced dimerization measured by FCCS. (A) Schematic of induced heterodimerization of hmKeima8.5-FKBP12 and mTFP1-FRB by rapamycin. (B) Cross-correlation curves, comparison before and after addition of rapamycin. (C) Rapamycin induced dimerization measured by the percentage of dual-color molecules over total molecule number of hmKeima8.5. The binding of FKBP12 and FRB causes increase in dual-color percentage. A control construct (mTFP1-P2A-hmKeima8.5) under rapamycin addition is unchanged. (D) Time course of heterodimerization in individual cells upon addition of different concentrations of rapamycin. (E) Two cross-correlation curves from cell 1 at 45 and 75 min after treatment with 100 nM rapamycin. (F) Schematic of association of Coumarin 343–conjugated monofunctional binder (SAS121) with FKBP12-hmKeima8.5, followed by competition with excess nonfluorescent monofunctional binder (MAZ1258). (G) FCCS Measurements show the complex of SAS121 with FKBP12-hmKeima8.5 and dissociation upon excess addition of MAZ1258.